299 related articles for article (PubMed ID: 12478091)
21. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
22. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Ichijo T; Ueshiba H; Nawata H; Yanase T
Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
[TBL] [Abstract][Full Text] [Related]
23. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and treatment of adrenal tumours: a review of 35 years' experience.
Xiao XR; Ye LY; Shi LX; Cheng GF; Li YT; Zhou BM
Br J Urol; 1998 Aug; 82(2):199-205. PubMed ID: 9722754
[TBL] [Abstract][Full Text] [Related]
25. Pediatric adrenocortical carcinoma.
Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
[TBL] [Abstract][Full Text] [Related]
26. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients.
Kasperlik-Załuska AA; Migdalska BM; Zgliczyński S; Makowska AM
Cancer; 1995 May; 75(10):2587-91. PubMed ID: 7736405
[TBL] [Abstract][Full Text] [Related]
27. Approach to patients with European Network for the Study of Adrenal Tumor stages I and II adrenocortical carcinomas.
Kastelan D; Muzurovic E; Dusek T
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):265-270. PubMed ID: 33709971
[TBL] [Abstract][Full Text] [Related]
28. Adrenocortical carcinoma: a clinician's update.
Fassnacht M; Libé R; Kroiss M; Allolio B
Nat Rev Endocrinol; 2011 Jun; 7(6):323-35. PubMed ID: 21386792
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
Bronswijk MJH; Laenen A; Bechter OE
Neoplasma; 2020 Jan; 67(1):209-213. PubMed ID: 31777255
[TBL] [Abstract][Full Text] [Related]
30. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
31. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
[TBL] [Abstract][Full Text] [Related]
32. [Adrenocortical carcinoma. Diagnostic work-up and treatment].
Johanssen S; Fassnacht M; Brix D; Koschker AC; Hahner S; Riedmiller H; Allolio B
Urologe A; 2008 Feb; 47(2):172-81. PubMed ID: 18030443
[TBL] [Abstract][Full Text] [Related]
33. Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients.
Takeuchi S; Balachandran A; Habra MA; Phan AT; Bassett RL; Macapinlac HA; Chuang HH
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2066-73. PubMed ID: 24990404
[TBL] [Abstract][Full Text] [Related]
34. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography (CT) scan identified necrosis, but is it a reliable single parameter for discerning between malignant and benign adrenocortical tumors?
Garay-Lechuga D; Pérez-Soto RH; Hernández-Acevedo JD; Butrón-Hernández D; Sierra-Salazar M; Pantoja-Millán JP; Herrera MF; Velázquez-Fernández D
Surgery; 2022 Jan; 171(1):104-110. PubMed ID: 34183180
[TBL] [Abstract][Full Text] [Related]
36. Primary non-functional extra-adrenal adrenocortical carcinoma.
Bani-Hani KE
Saudi Med J; 2003 Mar; 24(3):301-4. PubMed ID: 12704510
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical cancer treatment.
Patalano A; Brancato V; Mantero F
Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
[TBL] [Abstract][Full Text] [Related]
39. From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors.
Shen WT; Sturgeon C; Duh QY
J Surg Oncol; 2005 Mar; 89(3):186-92. PubMed ID: 15719374
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy in patients with adrenocortical carcinoma: a case-based discussion.
Puglisi S; Basile V; Sperone P; Terzolo M
Rev Endocr Metab Disord; 2023 Feb; 24(1):85-96. PubMed ID: 36414840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
